vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.
Sezzle Inc. is the larger business by last-quarter revenue ($78.2M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). Sezzle Inc. runs the higher net margin — 54.6% vs -19.9%, a 74.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 61.6%). Sezzle Inc. produced more free cash flow last quarter ($70.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 76.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.
ABCL vs SEZL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $44.9M | $78.2M |
| Net Profit | $-8.9M | $42.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 70.6% |
| Net Margin | -19.9% | 54.6% |
| Revenue YoY | 788.4% | 61.6% |
| Net Profit YoY | 73.9% | 68.3% |
| EPS (diluted) | $-0.03 | $1.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $78.2M | ||
| Q3 25 | $9.0M | $57.5M | ||
| Q2 25 | $17.1M | $52.0M | ||
| Q1 25 | $4.2M | $48.2M | ||
| Q4 24 | $5.0M | $48.4M | ||
| Q3 24 | $6.5M | $35.6M | ||
| Q2 24 | $7.3M | $30.2M | ||
| Q1 24 | $10.0M | $25.2M |
| Q4 25 | $-8.9M | $42.7M | ||
| Q3 25 | $-57.1M | $26.7M | ||
| Q2 25 | $-34.7M | $27.6M | ||
| Q1 25 | $-45.6M | $36.2M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | $-51.1M | $15.4M | ||
| Q2 24 | $-36.9M | $29.7M | ||
| Q1 24 | $-40.6M | $8.0M |
| Q4 25 | -63.7% | 70.6% | ||
| Q3 25 | -851.8% | 61.9% | ||
| Q2 25 | -290.2% | 69.4% | ||
| Q1 25 | -1479.6% | — | ||
| Q4 24 | — | 63.8% | ||
| Q3 24 | -1439.4% | 58.6% | ||
| Q2 24 | -1276.2% | 55.3% | ||
| Q1 24 | -551.5% | 54.8% |
| Q4 25 | -19.9% | 54.6% | ||
| Q3 25 | -637.8% | 46.4% | ||
| Q2 25 | -203.3% | 53.1% | ||
| Q1 25 | -1077.2% | 75.1% | ||
| Q4 24 | — | 52.4% | ||
| Q3 24 | -785.4% | 43.4% | ||
| Q2 24 | -504.3% | 98.4% | ||
| Q1 24 | -408.0% | 31.7% |
| Q4 25 | $-0.03 | $1.19 | ||
| Q3 25 | $-0.19 | $0.75 | ||
| Q2 25 | $-0.12 | $0.78 | ||
| Q1 25 | $-0.15 | $1.00 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | $-0.17 | $0.44 | ||
| Q2 24 | $-0.13 | $0.82 | ||
| Q1 24 | $-0.14 | $0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $64.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $169.8M |
| Total Assets | $1.4B | $400.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $64.1M | ||
| Q3 25 | $83.2M | $104.1M | ||
| Q2 25 | $92.4M | $88.9M | ||
| Q1 25 | $159.3M | $88.9M | ||
| Q4 24 | $156.3M | $73.2M | ||
| Q3 24 | $126.6M | $80.1M | ||
| Q2 24 | $148.3M | $58.0M | ||
| Q1 24 | $123.6M | $77.8M |
| Q4 25 | $966.9M | $169.8M | ||
| Q3 25 | $964.0M | $155.3M | ||
| Q2 25 | $1.0B | $130.4M | ||
| Q1 25 | $1.0B | $125.8M | ||
| Q4 24 | $1.1B | $87.8M | ||
| Q3 24 | $1.1B | $61.1M | ||
| Q2 24 | $1.1B | $50.3M | ||
| Q1 24 | $1.1B | $29.6M |
| Q4 25 | $1.4B | $400.2M | ||
| Q3 25 | $1.4B | $367.0M | ||
| Q2 25 | $1.4B | $350.6M | ||
| Q1 25 | $1.3B | $298.1M | ||
| Q4 24 | $1.4B | $298.4M | ||
| Q3 24 | $1.4B | $252.9M | ||
| Q2 24 | $1.4B | $212.1M | ||
| Q1 24 | $1.5B | $195.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $70.6M |
| Free Cash FlowOCF − Capex | $-44.6M | $70.6M |
| FCF MarginFCF / Revenue | -99.4% | 90.2% |
| Capex IntensityCapex / Revenue | 21.9% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $209.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $70.6M | ||
| Q3 25 | $-52.6M | $63.7M | ||
| Q2 25 | $-32.4M | $23.1M | ||
| Q1 25 | $-11.6M | $52.5M | ||
| Q4 24 | $-108.6M | $57.4M | ||
| Q3 24 | $-28.9M | $35.1M | ||
| Q2 24 | $-30.0M | $22.2M | ||
| Q1 24 | $-41.7M | $16.0M |
| Q4 25 | $-44.6M | $70.6M | ||
| Q3 25 | $-61.5M | $63.6M | ||
| Q2 25 | $-45.8M | $22.7M | ||
| Q1 25 | $-22.2M | $52.5M | ||
| Q4 24 | $-187.0M | $57.4M | ||
| Q3 24 | $-47.4M | $35.1M | ||
| Q2 24 | $-50.1M | $22.2M | ||
| Q1 24 | $-65.8M | $16.0M |
| Q4 25 | -99.4% | 90.2% | ||
| Q3 25 | -687.0% | 110.6% | ||
| Q2 25 | -267.9% | 43.6% | ||
| Q1 25 | -524.0% | 108.9% | ||
| Q4 24 | -3702.8% | 118.5% | ||
| Q3 24 | -728.4% | 98.6% | ||
| Q2 24 | -683.8% | 73.4% | ||
| Q1 24 | -661.5% | 63.3% |
| Q4 25 | 21.9% | 0.1% | ||
| Q3 25 | 99.7% | 0.3% | ||
| Q2 25 | 78.2% | 0.8% | ||
| Q1 25 | 251.1% | 0.1% | ||
| Q4 24 | 1552.7% | 0.1% | ||
| Q3 24 | 284.6% | 0.0% | ||
| Q2 24 | 274.6% | 0.1% | ||
| Q1 24 | 242.5% | 0.0% |
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 1.45× | ||
| Q4 24 | — | 2.26× | ||
| Q3 24 | — | 2.27× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 2.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
SEZL
| Merchant And Partner Income | $28.9M | 37% |
| Transaction Income | $25.9M | 33% |
| Income From Other Services Late Payment Fees | $20.5M | 26% |
| Other | $2.9M | 4% |